Bupropion hydrochloride (Zyban): Stock issue resolved
7 January 2020: Stock of Zyban has arrived and been released from the supplier.
About the supply issue: In December 2020, GlaxoSmithKline, the supplier of Zyban, had to manage low stock levels caused by shipping delays.
About Zyban (bupropion hydrochloride)
Zyban is indicated for the treatment of nicotine dependence in adults aged 18 and older as an aid to smoking cessation.
Who to contact
If you have questions about supply of Zyban, we recommend you contact your wholesaler.
If you have questions about funding, contact PHARMAC:
- email: enquiry@pharmac.govt.nz
- phone: 0800 660 050